These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6332972)

  • 1. Phenylbutazone off benefits list.
    Auerbach E
    Med J Aust; 1984 Aug; 141(4):261-2. PubMed ID: 6332972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nephrotoxicity of antirheumatic drugs. I. Effect of nonsteroid antirheumatic drugs on urine enzymes].
    Trnavský K; Rovenský J
    Fysiatr Revmatol Vestn; 1972 Aug; 50(4):166-71. PubMed ID: 4538245
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacotherapy in rheumatic diseases].
    Munthe E
    Tidsskr Nor Laegeforen; 1971 Jan; 91(3):219-21. PubMed ID: 5312884
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenylbutazone off benefits list.
    Smith GL
    Med J Aust; 1984 Oct; 141(8):551-2. PubMed ID: 6482811
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some notes from the study tour to Geneva].
    Hándlová D; Kanková D
    Fysiatr Revmatol Vestn; 1971 Aug; 49(4):185-7. PubMed ID: 5315099
    [No Abstract]   [Full Text] [Related]  

  • 6. An alkaline phenylbutazone preparation.
    Practitioner; 1969 Sep; 203(215):357-60. PubMed ID: 4308703
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with delta-butazolidin].
    Gukelberger M; Dübi B
    Praxis; 1967 Dec; 56(51):1730-3. PubMed ID: 5303388
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ambulatory therapy of rheumatism using Anarthral].
    Weikert F
    Munch Med Wochenschr; 1971 Sep; 113(28):1230-3. PubMed ID: 5315478
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electrometric demonstration of hypersensitivity to antirheumatic drugs].
    Vlcek F
    Arch Klin Exp Dermatol; 1970; 237(1):207-9. PubMed ID: 4244588
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phenylbutazone, the black 'horse' of the NSAID family?].
    de Grauw J; Lipman LJ
    Tijdschr Diergeneeskd; 2008 Mar; 133(6):232-5. PubMed ID: 18429404
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dangers of the modern therapy for rheumatism].
    Schuster E
    Dtsch Gesundheitsw; 1966 Mar; 21(11):491-3. PubMed ID: 5298922
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gold therapy in rheumatic diseases].
    Mathies H
    Dtsch Med Wochenschr; 1971 Jan; 96(4):179. PubMed ID: 5312829
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy of rheumatic diseases, especially using Delta-Butazolidin].
    Winkler R
    Med Monatsschr; 1970 Nov; 24(11):516-8. PubMed ID: 5313955
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of paracetamol-phenylbutazone combination in rheumatic diseases of professional motorists].
    de Mattos H
    Hospital (Rio J); 1968 Aug; 74(2):543-8. PubMed ID: 5308680
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trimethylgallic ester of phenylbutazone, new derivative of phenylbutazone].
    Marqués J; Muriach V; Barceló P
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):229-32. PubMed ID: 5307375
    [No Abstract]   [Full Text] [Related]  

  • 16. The current clinical status of gold therapy in rheumatic diseases.
    Kaye RL
    J Rheumatol Suppl; 1982; 8():124-31. PubMed ID: 6982338
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gold therapy of rheumatic diseases I. Comparative studies in gold content of blood serum following application of sanocrysin and aurodetoxin].
    Eberl R; Altmann H
    Wien Klin Wochenschr; 1969 Dec; 81(52):950-2. PubMed ID: 5311194
    [No Abstract]   [Full Text] [Related]  

  • 18. [Percutaneous therapy with sodium phenylbutazone ointment in various traumatic and rheumatic diseases (preliminary observations)].
    Wettreich W; Berg RS
    Rev Bras Med; 1965 Aug; 22(8):505-10. PubMed ID: 5322120
    [No Abstract]   [Full Text] [Related]  

  • 19. [1st clinical test in rheumatology using a new derivative of phenylbutazone (trimethylgallic ester of phenylbutazone)].
    Pelegrín Navarro A
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):225-8. PubMed ID: 5307374
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological properties of pyrazolone and pyrazolidine derivatives (review of the literature)].
    Mokhort NA; Nazarenko NN; Kondratiuk VI
    Vrach Delo; 1984 Mar; (3):39-45. PubMed ID: 6372242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.